Medindia
Medindia LOGIN REGISTER
Advertisement

Extrel CMS Announces ATEX Approval for Process Mass Spectrometer

Monday, April 14, 2008 General News
Advertisement
PITTSBURGH, April 13 Extrel CMS announces ATEX approvalfor process mass spectrometer. The MAX300-IGX Industrial Mass Spectrometer issuitable for use in potentially explosive atmospheres.
Advertisement

The Extrel MAX300-IGX Process Mass Spectrometer has obtained ATEX approvalfor installations in Zone 1 areas. The MAX300-IGX version will meet the ATEXarea classification requirements of European Pharmaceutical and Petrochemicalproducers. The MAX300-IGX is the newest addition to Extrel's process massspectrometer product line. The MAX300-IG is also available in general purpose,hazardous area and CSA certified versions.
Advertisement

The Extrel MAX300 series Mass Spectrometers are the seventh generation ofhigh performance online quadrupole mass spectrometers. The MAX300 providesreal time gas analysis and is suitable for a variety of applicationsincluding: pharmaceutical solvent drying, fermentation control, ethylene,ethylene oxide, ambient air monitoring, ammonia process control and varioussteel processes.

About Extrel CMS:

Extrel CMS is an ISO 9001:2000 quality management system certifiedmanufacturer of mass spectrometers for Process Control, Process Development,Basic Research, and QA/QC Laboratories. Extrel's analyzers and massspectrometer components are used in a wide range of markets including:Hydrocarbon Processing, Chemicals, Environmental, Pharmaceutical,Semiconductor, Steel, Materials, Energy, Aerospace and Automotive.

For more information contact Extrel CMS, 575 Epsilon Drive, Pittsburgh, PA15238. Phone: 412-963-7530. Fax: 412-963-6578. Web Site: www.extrel.com

This press release was issued through 24-7PressRelease.com. For furtherinformation, visit http://www.24-7pressrelease.com.

SOURCE Extrel CMS
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close